Search all trials

Find therapies in clinical trials near you – page 13

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Marginal zone lymphoma

Not recruiting

Registered drugNo placebo

Study of Acalabrutinib and Tafasitamab for Patients with Previously Treated Marginal Zone Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Neoplasm malignant

Not recruiting

Registered drugNo placebo

Safety Study of GEN1046 and Pembrolizumab in Patients with Malignant Solid Tumors

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Acasunlimab

Contact Research Centre

B-cell lymphoma recurrent+1

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Glofitamab and Obinutuzumab for Patients with Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Glofitamab

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study of venetoclax with fludarabine, cytarabine and idarubicin combination therapy in newly diagnosed patients with intermediate or high-risk Acute Myeloid Leukemia

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cytarabine

Contact Research Centre

Mantle cell lymphoma recurrent+1

Not recruiting

Registered drugNo placebo

Study on Loncastuximab Tesirine for Patients with Relapsed or Refractory Mantle Cell Lymphoma After Immunochemotherapy with Rituximab, Bendamustine, and Cytarabine

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Loncastuximab Tesirine

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Ineligible for Transplant

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carfilzomib

Contact Research Centre

K-ras gene mutation+2

Not recruiting

Registered drugNo placebo

Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Cholangiocarcinoma

Not recruiting

Registered drugNo placebo

Study Comparing Pemigatinib and Gemcitabine Plus Cisplatin for First-Line Treatment in Patients with Unresectable or Metastatic Cholangiocarcinoma with FGFR2 Rearrangement

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Gastric cancer+2

Not recruiting

Registered drugNo placebo

Study of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Calcium Folinate

Contact Research Centre

Mantle cell lymphoma

Not recruiting

Registered drugNo placebo

Study on Rituximab, Bendamustine, Cytarabine, and Venetoclax for High-Risk Elderly Patients with Mantle Cell Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cytarabine

Contact Research Centre

Colorectal cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing Panitumumab and Regorafenib Sequence for Patients with Metastatic Colorectal Cancer Resistant to Previous Treatments

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Panitumumab

Contact Research Centre

Acute lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study on Ponatinib and Chemotherapy for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cytarabine

Contact Research Centre

Find therapies in clinical trials near you – page 13

232 trials match your criteria

Marginal zone lymphoma

Study of Acalabrutinib and Tafasitamab for Patients with Previously Treated Marginal Zone Lymphoma

Neoplasm malignant

Safety Study of GEN1046 and Pembrolizumab in Patients with Malignant Solid Tumors

B-cell lymphoma recurrent+1

Study on the Safety and Effectiveness of Glofitamab and Obinutuzumab for Patients with Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Acute myeloid leukaemia

Study of venetoclax with fludarabine, cytarabine and idarubicin combination therapy in newly diagnosed patients with intermediate or high-risk Acute Myeloid Leukemia

Mantle cell lymphoma recurrent+1

Study on Loncastuximab Tesirine for Patients with Relapsed or Refractory Mantle Cell Lymphoma After Immunochemotherapy with Rituximab, Bendamustine, and Cytarabine

Plasma cell myeloma

Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Ineligible for Transplant

K-ras gene mutation+2

Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

Cholangiocarcinoma

Study Comparing Pemigatinib and Gemcitabine Plus Cisplatin for First-Line Treatment in Patients with Unresectable or Metastatic Cholangiocarcinoma with FGFR2 Rearrangement

Gastric cancer+2

Study of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer

Mantle cell lymphoma

Study on Rituximab, Bendamustine, Cytarabine, and Venetoclax for High-Risk Elderly Patients with Mantle Cell Lymphoma

Colorectal cancer metastatic

Study Comparing Panitumumab and Regorafenib Sequence for Patients with Metastatic Colorectal Cancer Resistant to Previous Treatments

Acute lymphocytic leukaemia

Study on Ponatinib and Chemotherapy for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.